Archive of the Category 'Research'
Dr. Della Valle and Colleagues Win the “Best Poster Award” at the 30th AAHKS Annual Meeting in the Infection Clinical Category
Dr. Della Valle and colleagues were the 30th AAHKS Annual Meeting recipients of the “Best Poster Award” in the Infection Clinical Category.
About the Study:
When a total hip replacement gets infected, a temporary antibiotic cement spacer is used as part of a two-stage surgery, and the spacer can either immobilize the hip (“static”) or allow it to have motion (“articulating”). In this multi-center study, patients were randomized to one of the spacer types so that outcomes could be compared. Operative time was similar between the groups, but static spacers were associated with significantly longer hospital stays after surgery, and outcomes at an average of 3.2 years postoperatively generally favored articulating spacers.
Dr. Della Valle’s co-authors included:
Cindy R. Nahhas, MD
Scott Sporer, MD
Peter N. Chalmers, MD
Javad Parvizi, MD
Gregory K. Deirmengian, MD
Antonia F. Chen, MD/MBA
Chris Culvern, MSc
Mario Moric, MS
Dr. Della Valle’s Study on Opioid Pill Prescriptions featured in Orthopedics This Week
Dr. Della Valle is the co-author of a new study entitled, “Who is prescribing opioids preoperatively? A survey of new patients presenting to tertiary care adult reconstruction clinics”. The study looks at the opioid prescription patterns for 461 consecutive new patients with painful and possibly arthritic hips or knees.
Orthopedics This Week has published an article about the study. Dr. Della Valle is quoted in the article, “Over the past several years we have had many patients come in after surgery and say they did not use all of their pills and they did not know what to do with the pills they had leftover. Thus, we decided to do a study to see if we can send patients home with fewer pills while still adequately controlling their pain.”
Midwest Orthopaedics at Rush Article on Two Recent Opioid Studies
Learn more about two recent studies examining the use of opioids that Dr. Della Valle was involved with on the Midwest Orthopaedics at Rush web site at https://www.rushortho.com/news/recent-studies-examine-use-of-opioids
Dr. Della Valle’s Manuscript One of Top Three Abstracts for 2019 Rush Surgical Society Annual Meeting
Dr. Della Valle’s manuscript, “Large Opioid Prescriptions Are Unnecessary After Total Joint Arthroplasty: A Randomized Controlled Trial” has been awarded one of the top three abstracts for the 2019 Rush Surgical Society Annual Meeting.
About the manuscript: A majority of patients in the United States receive over 90 opioid pills after hip or knee replacement surgery. The results from this study found that these large opioid prescriptions are unnecessary as they leave patients with an excess of unused opioid pills. A smaller prescription of 30 opioid pills is sufficient for a majority of patients undergoing hip or knee replacement.
Dr. Della Valle’s Manuscript Wins Carl L. Nelson, M.D. Physician in Training Award
Dr. Della Valle’s manuscript, “Large Opioid Prescriptions Are Unnecessary After Total Joint Arthroplasty: A Randomized Controlled Trial” has won the $1,000 Carl L. Nelson, M.D. Physician in Training Award. The Program Committee of the Mid-America Orthopaedic Association has selected the paper and three other papers for prizes.
About the manuscript: A majority of patients in the United States receive over 90 opioid pills after hip or knee replacement surgery. The results from this study found that these large opioid prescriptions are unnecessary as they leave patients with an excess of unused opioid pills. A smaller prescription of 30 opioid pills is sufficient for a majority of patients undergoing hip or knee replacement.
Dr. Della Valle’s Paper Wins The Knee Society’s Mark Coventry, MD Award
Dr. Della Valle’s paper entitled, “A Multi-center Randomized Clinical Trial of Tranexamic Acid in Revision Total Knee Arthroplasty: Does the Dosing Regimen Matter?” has won The Knee Society’s Mark Coventry, MD Award.
Revision total knee arthroplasty is a complex surgery that has a higher risk of blood loss than primary total knee arthroplasty. In this multi-center, prospective, randomized controlled trial we evaluated different dosing and administration routes of tranexamic acid, a medication shown to reduce blood loss after primary and revision total knee arthroplasty. This study found that all tranexamic dosing regimens were similarly effective methods of blood management in revision total knee arthroplasty. This study supports that surgeons should consider using the lowest effective dose and the least costly regimen for tranexamic acid use in revision total knee arthroplasty.
The paper will be presented at The Knee Society/AAHKS Specialty Day program (AAOS 2019 Annual Meeting) on Saturday, March 16, in Las Vegas, NV.
Dr. Della Valle Manuscript Awared the 2018 James A. Rand Young Investigator’s Award
Dr. Della Valle recently co-authored a manuscript entitled “Large Opioid Prescriptions are Unnecessary after Total Joint Arthroplasty: A Randomized Controlled Trial”. The manuscript was awarded the 2018 James A. Rand Young Investigator’s Award to be presented at the AAHKS meeting November 1-4 in Dallas, TX.
About the study: “A majority of patients in the United States receive over 90 opioid pills after hip or knee replacement surgery. The results from this study found that these large opioid prescriptions are unnecessary as they leave patients with an excess of unused opioid pills. A smaller prescription of 30 opioid pills is sufficient for a majority of patients undergoing hip or knee replacement.”
US News & World Report: Penicillin Misconceptions May Raise Post-Op Infection Risk
US News & World Report recently published an article entitled “Penicillin Misconceptions May Raise Post-Op Infection Risk”.
The article says, “Surgical patients who report having a penicillin allergy face a 50 percent higher risk for a post-op infection compared to patients who report no drug allergy, new research finds. Researchers from Massachusetts General Hospital attributed the higher surgical-site infection rate to the use of alternative antibiotics.”
Home Beats Rehab for Knee, Hip Replacement Recovery
The a recent study by past AAOS President William J. Hozack, MD and colleagues concluded that “patients who go straight home from the hospital following hip or knee replacement surgery recover as well as, or better than, those who first go to a rehabilitation center.”
Orthopedics Today: “Direct anterior, posterior approach yielded similar outcomes after THA”
Orthopedics Today recently published an article entitled, “Direct anterior, posterior approach yielded similar outcomes after THA”. The article describes how researchers found no differences in the dislocation rate between the direct anterior vs. posterior approach.
The article says, “Use of the direct anterior approach or posterior approach during total hip arthroplasty resulted in similar short-term outcomes and complications, according to results presented at the Current Concepts in Joint Replacement Spring Meeting.”
